Document is current

Any future updates will be listed below

Clinical Course After Initiation of Nivolumab Therapy in Patients with EGFR-Mutated Non-Small Cell Lung Cancer With or Without Pd-L1 Expression

Crossref DOI link: https://doi.org/10.1007/s40487-017-0053-3

Published Online: 2017-10-20

Published Print: 2017-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark